LY-255582
LY-255582 is a potent opioid receptor antagonist that has been studied for its potential therapeutic applications. It is a synthetic compound that interacts with the opioid receptor system in the brain and other parts of the body.
Pharmacology[edit]
LY-255582 acts primarily as an antagonist at the mu-opioid receptor (MOR), delta-opioid receptor (DOR), and kappa-opioid receptor (KOR). By blocking these receptors, LY-255582 can inhibit the effects of endogenous opioids and opioid drugs. This makes it a potential candidate for the treatment of opioid addiction and opioid overdose.
Mechanism of Action[edit]
The mechanism of action of LY-255582 involves its binding to the opioid receptors, preventing the activation of these receptors by endogenous ligands such as endorphins and enkephalins, as well as exogenous opioid drugs like morphine and heroin. This blockade can reduce the euphoric and analgesic effects of opioids, which is beneficial in treating addiction and overdose.
Therapeutic Applications[edit]
LY-255582 has been investigated for several therapeutic applications, including:
- Opioid addiction: By blocking the effects of opioids, LY-255582 may help in reducing cravings and withdrawal symptoms in individuals addicted to opioids.
- Opioid overdose: As an opioid receptor antagonist, LY-255582 can be used to reverse the life-threatening effects of opioid overdose, similar to naloxone.
- Pain management: Although primarily an antagonist, LY-255582's interaction with the opioid system may have implications for pain management, particularly in reducing opioid tolerance and dependence.
Research and Development[edit]
Research on LY-255582 is ongoing, with studies focusing on its efficacy, safety, and potential side effects. Clinical trials are necessary to fully understand its therapeutic potential and to determine the appropriate dosing regimens.
See Also[edit]
References[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
